NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022

Deborah K. Armstrong; Ronald D. Alvarez; Floor J. Backes; Jamie N. Bakkum-Gamez; Lisa Barroilhet; Kian Behbakht; Andrew Berchuck; Lee May Chen; Viola C. Chitiyo; Mihaela Cristea; Maria DeRosa; Eric L. Eisenhauer; David M. Gershenson; Heidi J. Gray; Rachel Grisham; Ardeshir Hakam; Angela Jain; Amer Karam; Gottfried E. Konecny; Charles A. Leath; Gary Leiserowitz; Joyce Liu; Lainie Martin; Daniela Matei; Michael McHale; Karen McLean; David S. Miller; Sanja Percac-Lima; Steven W. Remmenga; John Schorge; Daphne Stewart; Premal H. Thaker; Roberto Vargas; Andrea Wahner Hendrickson; Theresa L. Werner; Emese Zsiros; Mary A. Dwyer; Lisa Hang

doi:10.6004/jnccn.2022.0047

NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022

Deborah K. Armstrong
, Ronald D. Alvarez
, Floor J. Backes
, Jamie N. Bakkum-Gamez
, Lisa Barroilhet
, Kian Behbakht
, Andrew Berchuck
, Lee May Chen
, Viola C. Chitiyo
, Mihaela Cristea
, Maria DeRosa
, Eric L. Eisenhauer
, David M. Gershenson
, Heidi J. Gray
, Rachel Grisham
, Ardeshir Hakam
, Angela Jain
, Amer Karam
, Gottfried E. Konecny
, Charles A. Leath

Gary Leiserowitz, Joyce Liu, Lainie Martin, Daniela Matei, Michael McHale, Karen McLean, David S. Miller, Sanja Percac-Lima, Steven W. Remmenga, John Schorge, Daphne Stewart, Premal H. Thaker, Roberto Vargas, Andrea Wahner Hendrickson, Theresa L. Werner, Emese Zsiros, Mary A. Dwyer, Lisa Hang

Johns Hopkins University
Vanderbilt University
Ohio State University
Mayo Clinic
University of Wisconsin-Madison
University of Colorado
Duke University
University of California at San Francisco
Memorial Sloan-Kettering Cancer Center
City of Hope Comprehensive Cancer Center
Massachusetts General Hospital Cancer Center
University of Texas MD Anderson Cancer Center
University of Washington
University of South Florida
Stanford University
University of California at Los Angeles
University of Alabama at Birmingham
University of California at Davis
Dana-Farber/Brigham and Women's Cancer Center
University of Pennsylvania
Northwestern University
University of California at San Diego
University of Michigan, Ann Arbor
Harold C. Simmons Comprehensive Cancer Center
University of Nebraska Medical Center
St. Jude Children Research Hospital
Washington University St. Louis
Case Western Reserve University
University of Utah
Roswell Park Comprehensive Cancer Center
National Comprehensive Cancer Network

Research output: Contribution to journal › Article › peer-review

341 Scopus citations

Abstract

Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States, with less than half of patients living .5 years following diagnosis. The NCCN Guidelines for Ovarian Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with ovarian, fallopian tube, and primary peritoneal cancers. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised guidance on alternative chemotherapy regimens for patients with advanced age and/or comorbidities, a new algorithm for recurrent low-grade serous carcinoma based on developing research and novel therapeutic agents, and updated language regarding tumor molecular analysis applications in ovarian cancer.

Original language	English
Pages (from-to)	972-980
Number of pages	9
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	20
Issue number	9
DOIs	https://doi.org/10.6004/jnccn.2022.0047
State	Published - Sep 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Carcinoma, Ovarian Epithelial/diagnosis
Cystadenocarcinoma, Serous/pathology
Female
Humans
Ovarian Neoplasms/diagnosis
Peritoneal Neoplasms
United States

Access to Document

10.6004/jnccn.2022.0047

Cite this

Armstrong, D. K., Alvarez, R. D., Backes, F. J., Bakkum-Gamez, J. N., Barroilhet, L., Behbakht, K., Berchuck, A., Chen, L. M., Chitiyo, V. C., Cristea, M., DeRosa, M., Eisenhauer, E. L., Gershenson, D. M., Gray, H. J., Grisham, R., Hakam, A., Jain, A., Karam, A., Konecny, G. E., ... Hang, L. (2022). NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022. JNCCN Journal of the National Comprehensive Cancer Network, 20(9), 972-980. https://doi.org/10.6004/jnccn.2022.0047

@article{c979134f7e2a42158fcdaf3c5f265641,

title = "NCCN Guidelines{\textregistered} Insights: Ovarian Cancer, Version 3.2022",

abstract = "Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States, with less than half of patients living .5 years following diagnosis. The NCCN Guidelines for Ovarian Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with ovarian, fallopian tube, and primary peritoneal cancers. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised guidance on alternative chemotherapy regimens for patients with advanced age and/or comorbidities, a new algorithm for recurrent low-grade serous carcinoma based on developing research and novel therapeutic agents, and updated language regarding tumor molecular analysis applications in ovarian cancer.",

keywords = "Carcinoma, Ovarian Epithelial/diagnosis, Cystadenocarcinoma, Serous/pathology, Female, Humans, Ovarian Neoplasms/diagnosis, Peritoneal Neoplasms, United States",

author = "Armstrong, \{Deborah K.\} and Alvarez, \{Ronald D.\} and Backes, \{Floor J.\} and Bakkum-Gamez, \{Jamie N.\} and Lisa Barroilhet and Kian Behbakht and Andrew Berchuck and Chen, \{Lee May\} and Chitiyo, \{Viola C.\} and Mihaela Cristea and Maria DeRosa and Eisenhauer, \{Eric L.\} and Gershenson, \{David M.\} and Gray, \{Heidi J.\} and Rachel Grisham and Ardeshir Hakam and Angela Jain and Amer Karam and Konecny, \{Gottfried E.\} and Leath, \{Charles A.\} and Gary Leiserowitz and Joyce Liu and Lainie Martin and Daniela Matei and Michael McHale and Karen McLean and Miller, \{David S.\} and Sanja Percac-Lima and Remmenga, \{Steven W.\} and John Schorge and Daphne Stewart and Thaker, \{Premal H.\} and Roberto Vargas and Hendrickson, \{Andrea Wahner\} and Werner, \{Theresa L.\} and Emese Zsiros and Dwyer, \{Mary A.\} and Lisa Hang",

year = "2022",

month = sep,

doi = "10.6004/jnccn.2022.0047",

language = "English",

volume = "20",

pages = "972--980",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "9",

}

Armstrong, DK, Alvarez, RD, Backes, FJ, Bakkum-Gamez, JN, Barroilhet, L, Behbakht, K, Berchuck, A, Chen, LM, Chitiyo, VC, Cristea, M, DeRosa, M, Eisenhauer, EL, Gershenson, DM, Gray, HJ, Grisham, R, Hakam, A, Jain, A, Karam, A, Konecny, GE, Leath, CA, Leiserowitz, G, Liu, J, Martin, L, Matei, D, McHale, M, McLean, K, Miller, DS, Percac-Lima, S, Remmenga, SW, Schorge, J, Stewart, D, Thaker, PH, Vargas, R, Hendrickson, AW, Werner, TL, Zsiros, E, Dwyer, MA & Hang, L 2022, 'NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022', JNCCN Journal of the National Comprehensive Cancer Network, vol. 20, no. 9, pp. 972-980. https://doi.org/10.6004/jnccn.2022.0047

TY - JOUR

T1 - NCCN Guidelines® Insights

T2 - Ovarian Cancer, Version 3.2022

AU - Armstrong, Deborah K.

AU - Alvarez, Ronald D.

AU - Backes, Floor J.

AU - Bakkum-Gamez, Jamie N.

AU - Barroilhet, Lisa

AU - Behbakht, Kian

AU - Berchuck, Andrew

AU - Chen, Lee May

AU - Chitiyo, Viola C.

AU - Cristea, Mihaela

AU - DeRosa, Maria

AU - Eisenhauer, Eric L.

AU - Gershenson, David M.

AU - Gray, Heidi J.

AU - Grisham, Rachel

AU - Hakam, Ardeshir

AU - Jain, Angela

AU - Karam, Amer

AU - Konecny, Gottfried E.

AU - Leath, Charles A.

AU - Leiserowitz, Gary

AU - Liu, Joyce

AU - Martin, Lainie

AU - Matei, Daniela

AU - McHale, Michael

AU - McLean, Karen

AU - Miller, David S.

AU - Percac-Lima, Sanja

AU - Remmenga, Steven W.

AU - Schorge, John

AU - Stewart, Daphne

AU - Thaker, Premal H.

AU - Vargas, Roberto

AU - Hendrickson, Andrea Wahner

AU - Werner, Theresa L.

AU - Zsiros, Emese

AU - Dwyer, Mary A.

AU - Hang, Lisa

PY - 2022/9

Y1 - 2022/9

N2 - Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States, with less than half of patients living .5 years following diagnosis. The NCCN Guidelines for Ovarian Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with ovarian, fallopian tube, and primary peritoneal cancers. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised guidance on alternative chemotherapy regimens for patients with advanced age and/or comorbidities, a new algorithm for recurrent low-grade serous carcinoma based on developing research and novel therapeutic agents, and updated language regarding tumor molecular analysis applications in ovarian cancer.

AB - Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States, with less than half of patients living .5 years following diagnosis. The NCCN Guidelines for Ovarian Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with ovarian, fallopian tube, and primary peritoneal cancers. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised guidance on alternative chemotherapy regimens for patients with advanced age and/or comorbidities, a new algorithm for recurrent low-grade serous carcinoma based on developing research and novel therapeutic agents, and updated language regarding tumor molecular analysis applications in ovarian cancer.

KW - Carcinoma, Ovarian Epithelial/diagnosis

KW - Cystadenocarcinoma, Serous/pathology

KW - Female

KW - Humans

KW - Ovarian Neoplasms/diagnosis

KW - Peritoneal Neoplasms

KW - United States

UR - https://www.scopus.com/pages/publications/85137540169

U2 - 10.6004/jnccn.2022.0047

DO - 10.6004/jnccn.2022.0047

M3 - Article

C2 - 36075393

AN - SCOPUS:85137540169

SN - 1540-1405

VL - 20

SP - 972

EP - 980

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 9

ER -

NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this